To quantify the diagnostic utility of urinary lipocalin-2 as marker of nephritis in patients, we constructed an ROC curve (Figure 3), using urinary lipocalin-2/creatinine in patients with LN proven by biopsy (the current gold standard) and patients without nephritis. The gene discussed is LCN2; the disease is lobular neoplasia.